when will retatrutide be available in the us FDA Approved? Timeline, Trials & Projections (2026) Retatrutide FDA Approval Status: August

Full Phase 3 safety data, including long-term cardiovascular outcomes, is not yet available

Working with a qualified provider means getting baseline bloodwork done before starting, monitoring GH, IGF-1, liver enzymes, and glucose throughout your cycle, and having someone adjust your protocol based on how your body responds

Laboratory research record on Cagrilintide [PMID: 41259767] PubMed laboratory record discussing Cagrilintide in a research context

Injection technique and site rotation Proper injection technique affects both comfort and efficacy

Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain